A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.
about
Clinical significance of microRNAs in chronic and acute human leukemiaTherapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsHigher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemiamiR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse modelDifferential correlation analysis of glioblastoma reveals immune ceRNA interactions predictive of patient survivalAn mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.A three-gene expression-based risk score can refine the European LeukemiaNet AML classification.MicroRNA: an important regulator in acute myeloid leukemia.Prognostic significance of NPM1 mutation-modulated microRNA-mRNA regulation in acute myeloid leukemia.MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.Expression of a passenger miR-9* predicts favorable outcome in adults with acute myeloid leukemia less than 60 years of age.MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses.Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia.High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia.Identification of miRNA and genes involving in osteosarcoma by comprehensive analysis of microRNA and copy number variation data.Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.
P2860
Q26749533-999592F3-F11D-4919-AE2F-A4F33DE39E3EQ28071427-E0B199AF-27BA-4618-A30B-F7176C830389Q33746724-8164F7A1-581B-4344-9F40-A7870BF0971FQ33872395-D5C8AF44-9608-4384-A059-F2E96B673A9CQ33889001-0DB1C6EC-F2FF-4BBE-80C5-36D8AAD3B36CQ33892323-BC66FA4E-1AEC-4BAE-B9C7-630B2A843A14Q36292015-261FC610-1EBE-4BD9-BD68-894CBA093240Q36629521-E3C00BCA-1CA0-46A5-ACD7-2684CBD442A3Q37228655-420E6556-0ED1-43A7-9415-2755687B537AQ38735859-0B7AFD18-E72A-46C6-A7E7-AE5A7451C02DQ38834968-DBB6DBCF-A7C9-4758-8532-89FCCEEFEDE0Q40867295-6D032DA8-07FC-48C1-AFF6-5F55D1D43ADCQ41225296-970D7494-5CF3-43B3-A1B9-C1CA1C862A81Q42362052-69C61CC6-867F-486D-BFA0-403F2DCA3E53Q42366772-F3AB1F40-EC5E-4B66-BCB2-15930CDC3E60Q42700810-14020AB5-8820-4D52-AB5E-95941350DE3AQ46594200-B45A69FE-D1F0-4D94-8645-9B8EDD9EE2FBQ47347914-92A3172E-9366-4A78-808E-D30466038968
P2860
A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A 3-microRNA scoring system fo ...... ute myeloid leukemia patients.
@en
A 3-microRNA scoring system fo ...... ute myeloid leukemia patients.
@nl
type
label
A 3-microRNA scoring system fo ...... ute myeloid leukemia patients.
@en
A 3-microRNA scoring system fo ...... ute myeloid leukemia patients.
@nl
prefLabel
A 3-microRNA scoring system fo ...... ute myeloid leukemia patients.
@en
A 3-microRNA scoring system fo ...... ute myeloid leukemia patients.
@nl
P2093
P2860
P50
P356
P1433
P1476
A 3-microRNA scoring system fo ...... cute myeloid leukemia patients
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2014.333
P577
2014-11-27T00:00:00Z